This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Incyte Corporation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Charles Cole - Innovator in Cancer Treatment
Introduction
Charles Cole is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of medicine, particularly in the development of treatments for cancer. His innovative work has led to the creation of a patent that addresses critical health challenges.
Latest Patents
Charles Cole holds a patent for "Spirocyclic lactams as JAK2 V617F inhibitors." This patent presents spirocyclic lactam compounds that modulate the activity of the V617F variant of JAK2. These compounds are useful in the treatment of various diseases, including cancer. His work in this area showcases his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Cole is associated with Incyte Corporation, a leading biopharmaceutical company. His role at Incyte has allowed him to collaborate with other talented professionals in the field. His career is marked by a dedication to research and innovation, particularly in the area of cancer therapeutics.
Collaborations
Some of his notable coworkers include Kai Liu and Eddy W. Yue. Their collaborative efforts contribute to the ongoing research and development of effective treatments for cancer and other diseases.
Conclusion
Charles Cole's contributions to the field of medicine through his patent and work at Incyte Corporation highlight his role as an innovator in cancer treatment. His dedication to research and collaboration with other experts underscores the importance of innovation in addressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile